Copyright Reports & Markets. All rights reserved.

Global Travelers Vaccines Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Travelers Vaccines Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Meningococcal Vaccine
    • 1.3.3 Japanese Encephalitis Vaccine
    • 1.3.4 Yellow Fever Vaccine
    • 1.3.5 Hepatitis Vaccine
    • 1.3.6 Cholera Vaccine
    • 1.3.7 Other
  • 1.4 Market Analysis by End Users
    • 1.4.1 Overview: Global Travelers Vaccines Consumption Value by End Users: 2020 Versus 2024 Versus 2031
    • 1.4.2 Tourists
    • 1.4.3 Students
    • 1.4.4 Workers
    • 1.4.5 Others
  • 1.5 Global Travelers Vaccines Market Size & Forecast
    • 1.5.1 Global Travelers Vaccines Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Travelers Vaccines Sales Quantity (2020-2031)
    • 1.5.3 Global Travelers Vaccines Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 GlaxoSmithKline
    • 2.1.1 GlaxoSmithKline Details
    • 2.1.2 GlaxoSmithKline Major Business
    • 2.1.3 GlaxoSmithKline Travelers Vaccines Product and Services
    • 2.1.4 GlaxoSmithKline Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 GlaxoSmithKline Recent Developments/Updates
  • 2.2 Sanofi Pasteur
    • 2.2.1 Sanofi Pasteur Details
    • 2.2.2 Sanofi Pasteur Major Business
    • 2.2.3 Sanofi Pasteur Travelers Vaccines Product and Services
    • 2.2.4 Sanofi Pasteur Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Sanofi Pasteur Recent Developments/Updates
  • 2.3 Merck
    • 2.3.1 Merck Details
    • 2.3.2 Merck Major Business
    • 2.3.3 Merck Travelers Vaccines Product and Services
    • 2.3.4 Merck Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Merck Recent Developments/Updates
  • 2.4 Pfizer
    • 2.4.1 Pfizer Details
    • 2.4.2 Pfizer Major Business
    • 2.4.3 Pfizer Travelers Vaccines Product and Services
    • 2.4.4 Pfizer Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Pfizer Recent Developments/Updates
  • 2.5 CNBG
    • 2.5.1 CNBG Details
    • 2.5.2 CNBG Major Business
    • 2.5.3 CNBG Travelers Vaccines Product and Services
    • 2.5.4 CNBG Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 CNBG Recent Developments/Updates
  • 2.6 Sanofi Pasteur MSD
    • 2.6.1 Sanofi Pasteur MSD Details
    • 2.6.2 Sanofi Pasteur MSD Major Business
    • 2.6.3 Sanofi Pasteur MSD Travelers Vaccines Product and Services
    • 2.6.4 Sanofi Pasteur MSD Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Sanofi Pasteur MSD Recent Developments/Updates
  • 2.7 Serum Institute of India
    • 2.7.1 Serum Institute of India Details
    • 2.7.2 Serum Institute of India Major Business
    • 2.7.3 Serum Institute of India Travelers Vaccines Product and Services
    • 2.7.4 Serum Institute of India Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Serum Institute of India Recent Developments/Updates
  • 2.8 Biokangtai
    • 2.8.1 Biokangtai Details
    • 2.8.2 Biokangtai Major Business
    • 2.8.3 Biokangtai Travelers Vaccines Product and Services
    • 2.8.4 Biokangtai Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Biokangtai Recent Developments/Updates

3 Competitive Environment: Travelers Vaccines by Manufacturer

  • 3.1 Global Travelers Vaccines Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Travelers Vaccines Revenue by Manufacturer (2020-2025)
  • 3.3 Global Travelers Vaccines Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Travelers Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Travelers Vaccines Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Travelers Vaccines Manufacturer Market Share in 2024
  • 3.5 Travelers Vaccines Market: Overall Company Footprint Analysis
    • 3.5.1 Travelers Vaccines Market: Region Footprint
    • 3.5.2 Travelers Vaccines Market: Company Product Type Footprint
    • 3.5.3 Travelers Vaccines Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Travelers Vaccines Market Size by Region
    • 4.1.1 Global Travelers Vaccines Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Travelers Vaccines Consumption Value by Region (2020-2031)
    • 4.1.3 Global Travelers Vaccines Average Price by Region (2020-2031)
  • 4.2 North America Travelers Vaccines Consumption Value (2020-2031)
  • 4.3 Europe Travelers Vaccines Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Travelers Vaccines Consumption Value (2020-2031)
  • 4.5 South America Travelers Vaccines Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Travelers Vaccines Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Travelers Vaccines Sales Quantity by Type (2020-2031)
  • 5.2 Global Travelers Vaccines Consumption Value by Type (2020-2031)
  • 5.3 Global Travelers Vaccines Average Price by Type (2020-2031)

6 Market Segment by End Users

  • 6.1 Global Travelers Vaccines Sales Quantity by End Users (2020-2031)
  • 6.2 Global Travelers Vaccines Consumption Value by End Users (2020-2031)
  • 6.3 Global Travelers Vaccines Average Price by End Users (2020-2031)

7 North America

  • 7.1 North America Travelers Vaccines Sales Quantity by Type (2020-2031)
  • 7.2 North America Travelers Vaccines Sales Quantity by End Users (2020-2031)
  • 7.3 North America Travelers Vaccines Market Size by Country
    • 7.3.1 North America Travelers Vaccines Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Travelers Vaccines Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Travelers Vaccines Sales Quantity by Type (2020-2031)
  • 8.2 Europe Travelers Vaccines Sales Quantity by End Users (2020-2031)
  • 8.3 Europe Travelers Vaccines Market Size by Country
    • 8.3.1 Europe Travelers Vaccines Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Travelers Vaccines Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Travelers Vaccines Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Travelers Vaccines Sales Quantity by End Users (2020-2031)
  • 9.3 Asia-Pacific Travelers Vaccines Market Size by Region
    • 9.3.1 Asia-Pacific Travelers Vaccines Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Travelers Vaccines Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Travelers Vaccines Sales Quantity by Type (2020-2031)
  • 10.2 South America Travelers Vaccines Sales Quantity by End Users (2020-2031)
  • 10.3 South America Travelers Vaccines Market Size by Country
    • 10.3.1 South America Travelers Vaccines Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Travelers Vaccines Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Travelers Vaccines Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Travelers Vaccines Sales Quantity by End Users (2020-2031)
  • 11.3 Middle East & Africa Travelers Vaccines Market Size by Country
    • 11.3.1 Middle East & Africa Travelers Vaccines Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Travelers Vaccines Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Travelers Vaccines Market Drivers
  • 12.2 Travelers Vaccines Market Restraints
  • 12.3 Travelers Vaccines Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Travelers Vaccines and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Travelers Vaccines
  • 13.3 Travelers Vaccines Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Travelers Vaccines Typical Distributors
  • 14.3 Travelers Vaccines Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Travelers Vaccines market size was valued at US$ 4091 million in 2024 and is forecast to a readjusted size of USD 7241 million by 2031 with a CAGR of 8.6% during review period.
    A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
    Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
    In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
    Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
    This report is a detailed and comprehensive analysis for global Travelers Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by End Users. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Travelers Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
    Global Travelers Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
    Global Travelers Vaccines market size and forecasts, by Type and by End Users, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
    Global Travelers Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (USD/Dose), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Travelers Vaccines
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Travelers Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India, Biokangtai, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Travelers Vaccines market is split by Type and by End Users. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End Users in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Meningococcal Vaccine
    Japanese Encephalitis Vaccine
    Yellow Fever Vaccine
    Hepatitis Vaccine
    Cholera Vaccine
    Other
    Market segment by End Users
    Tourists
    Students
    Workers
    Others
    Major players covered
    GlaxoSmithKline
    Sanofi Pasteur
    Merck
    Pfizer
    CNBG
    Sanofi Pasteur MSD
    Serum Institute of India
    Biokangtai
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Travelers Vaccines product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Travelers Vaccines, with price, sales quantity, revenue, and global market share of Travelers Vaccines from 2020 to 2025.
    Chapter 3, the Travelers Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Travelers Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by End Users, with sales market share and growth rate by Type, by End Users, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Travelers Vaccines market forecast, by regions, by Type, and by End Users, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Travelers Vaccines.
    Chapter 14 and 15, to describe Travelers Vaccines sales channel, distributors, customers, research findings and conclusion.

    Buy now